# Axsome Therapeutics, Inc. – aktieanalysens källarkiv Company page: https://spela.port0.org/company/axsome-therapeutics-inc Company JSON: https://spela.port0.org/company/axsome-therapeutics-inc/company.json Documents JSON: https://spela.port0.org/company/axsome-therapeutics-inc/documents.json Updated: 2026-08-06T07:19:29Z ## Market data - Nasdaq kurshistorik CSV: https://spela.port0.org/company/axsome-therapeutics-inc/market/history.csv - Nasdaq kurshistorik JSON: https://spela.port0.org/company/axsome-therapeutics-inc/market/history.json - Nasdaq manifest JSON: https://spela.port0.org/company/axsome-therapeutics-inc/market/manifest.json - SEC Company Facts JSON: https://spela.port0.org/company/axsome-therapeutics-inc/market/sec-companyfacts.json - SEC filing-manifest JSON: https://spela.port0.org/company/axsome-therapeutics-inc/market/sec-manifest.json - SEC sammanfattning JSON: https://spela.port0.org/company/axsome-therapeutics-inc/market/sec-summary.json ## Full-text source documents - SEC EDGAR | 8-K – 2026-07-15 – axsm-20260715.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-07-15-axsm-20260715-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-06-09 – axsm-20260605.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-06-09-axsm-20260605-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-06-09 – axsm-20260605.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-06-09-axsm-20260605-htm-2/fulltext.txt - SEC EDGAR | 8-K – 2026-06-03 – axsm-20260603.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-06-03-axsm-20260603-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-05-04 – axsm-20260504.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-05-04-axsm-20260504-htm/fulltext.txt - SEC EDGAR | 10-Q – 2026-05-04 – axsm-20260331.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-q-2026-05-04-axsm-20260331-htm/fulltext.txt - HTML part 1: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-q-2026-05-04-axsm-20260331-htm/part-001.html - HTML part 2: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-q-2026-05-04-axsm-20260331-htm/part-002.html - HTML part 3: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-q-2026-05-04-axsm-20260331-htm/part-003.html - SEC EDGAR | 8-K – 2026-04-30 – axsm-20260430.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-04-30-axsm-20260430-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-04-01 – axsm-20260401.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-04-01-axsm-20260401-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-02-23 – axsm-20260223.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-02-23-axsm-20260223-htm/fulltext.txt - SEC EDGAR | 10-K – 2026-02-23 – axsm-20251231.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-k-2026-02-23-axsm-20251231-htm/fulltext.txt - HTML part 1: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-k-2026-02-23-axsm-20251231-htm/part-001.html - HTML part 2: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-k-2026-02-23-axsm-20251231-htm/part-002.html - HTML part 3: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-k-2026-02-23-axsm-20251231-htm/part-003.html - HTML part 4: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-k-2026-02-23-axsm-20251231-htm/part-004.html - SEC EDGAR | 8-K – 2026-02-17 – axsm-20260217.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-02-17-axsm-20260217-htm/fulltext.txt - SEC EDGAR | 8-K – 2026-01-12 – axsm-20260112.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2026-01-12-axsm-20260112-htm/fulltext.txt - SEC EDGAR | 8-K – 2025-12-31 – axsm-20251231.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2025-12-31-axsm-20251231-htm/fulltext.txt - SEC EDGAR | 8-K – 2025-11-03 – axsm-20251103.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2025-11-03-axsm-20251103-htm/fulltext.txt - SEC EDGAR | 10-Q – 2025-11-03 – axsm-20250930.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-q-2025-11-03-axsm-20250930-htm/fulltext.txt - HTML part 1: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-q-2025-11-03-axsm-20250930-htm/part-001.html - HTML part 2: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-q-2025-11-03-axsm-20250930-htm/part-002.html - HTML part 3: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-10-q-2025-11-03-axsm-20250930-htm/part-003.html - SEC EDGAR | 8-K – 2025-08-20 – axsm-20250819.htm: https://spela.port0.org/company/axsome-therapeutics-inc/documents/sec-edgar-8-k-2025-08-20-axsm-20250819-htm/fulltext.txt